HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
RS 14203
a type IV cyclic nucleotide phosphodiesterase inhibitor; structure in first source
Also Known As:
RS-14203; RS14203
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Benzene Derivatives: 17
Nitrobenzenes: 7
RS 14203: 2
Nitro Compounds: 66
Nitrobenzenes: 7
RS 14203: 2
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Quinolines: 146
Quinolones: 2938
RS 14203: 2
Experts
1.
Chan, C C
: 1 article (09/2000)
2.
Robichaud, A
: 1 article (09/2000)
3.
Rodger, I W
: 1 article (09/2000)
4.
Savoie, C
: 1 article (09/2000)
Related Diseases
1.
Vomiting
02/01/1999 - "
The incidence of emesis was positively influenced by the dose of PDE IV inhibitors administered, allowing a rank order of potency: RS14203 > R-rolipram > S-rolipram > CT-2450 > CT-3405.
"
02/01/1999 - "
Emesis induced by RS14203 exhibited a dose-response relationship but no such relationship was seen for R-rolipram or CT-2450.
"
2.
Bradycardia
09/01/2000 - "
RS14203, (R)-rolipram, or CT-2450 (1-100 microg/kg iv) did not affect the bradycardia induced by vagal electrical stimulation.
"
Related Drugs and Biologics
1.
Rolipram
2.
CT 2450